FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200326863> ?p ?o ?g. }

• W4200326863 endingPage "2606" @default.
• W4200326863 startingPage "2599" @default.
• W4200326863 abstract "The development of resistance to available anticancer drugs is increasingly becoming a major challenge and new chemical entities could be unveiled to compensate for this therapeutic failure.The current study demonstrated whether N-protected and deprotected amino acid derivatives of 2- aminopyridine could attenuate tumor development using colorectal cancer cell lines.Biological assays were performed to investigate the anticancer potential of synthesized compounds. The in silico ADME profiling and docking studies were also performed by docking the designed compounds against the active binding site of beta-catenin (CTNNB1) to analyze the binding mode of these compounds. Four derivatives 4a, 4b, 4c, and 4d were selected for investigation of in vitro anticancer potential using colorectal cancer cell line HCT 116. The anti-tumor activities of synthesized compounds were further validated by evaluating the inhibitory effects of these compounds on the target protein beta-catenin through in vitro enzyme inhibitory assay.The docking analysis revealed favorable binding energies and interactions with the target proteins. The in vitro MTT assay on colorectal cancer cell line HCT 116 and HT29 revealed potential anti-tumor activities with an IC50 range of 3.7-8.1μM and 3.27-7.7 μM, respectively. The inhibitory properties of these compounds on the concentration of beta-catenin by ELISA revealed significant percent inhibition of target protein at 100 μg/ml.In conclusion, the synthesized compounds showed significant anti-tumor activities both in silico and in vitro, having potential for further investigating its role in colorectal cancer." @default.
• W4200326863 created "2021-12-31" @default.
• W4200326863 creator A5001114156 @default.
• W4200326863 creator A5004970725 @default.
• W4200326863 creator A5008758296 @default.
• W4200326863 creator A5012605139 @default.
• W4200326863 creator A5021988496 @default.
• W4200326863 creator A5041191047 @default.
• W4200326863 creator A5044808634 @default.
• W4200326863 creator A5083560821 @default.
• W4200326863 date "2022-08-01" @default.
• W4200326863 modified "2023-09-27" @default.
• W4200326863 title "Cytotoxic Evaluation and Molecular Docking Studies of Aminopyridine Derivatives as Potential Anticancer Agents" @default.
• W4200326863 cites W153332747 @default.
• W4200326863 cites W1823710096 @default.
• W4200326863 cites W1862015311 @default.
• W4200326863 cites W1963892864 @default.
• W4200326863 cites W1977282090 @default.
• W4200326863 cites W1985516721 @default.
• W4200326863 cites W1986556922 @default.
• W4200326863 cites W2008657782 @default.
• W4200326863 cites W2019227458 @default.
• W4200326863 cites W2058571113 @default.
• W4200326863 cites W2062533676 @default.
• W4200326863 cites W2076551313 @default.
• W4200326863 cites W2109785891 @default.
• W4200326863 cites W2110623520 @default.
• W4200326863 cites W2129875497 @default.
• W4200326863 cites W2158021558 @default.
• W4200326863 cites W2172446660 @default.
• W4200326863 cites W2317582029 @default.
• W4200326863 cites W2346497432 @default.
• W4200326863 cites W2474434404 @default.
• W4200326863 cites W2520632143 @default.
• W4200326863 cites W2591535357 @default.
• W4200326863 cites W2783151045 @default.
• W4200326863 cites W2787775113 @default.
• W4200326863 cites W2897408595 @default.
• W4200326863 cites W2923287877 @default.
• W4200326863 cites W2971393435 @default.
• W4200326863 cites W2978140511 @default.
• W4200326863 cites W2982215289 @default.
• W4200326863 cites W3000376411 @default.
• W4200326863 cites W3006464663 @default.
• W4200326863 cites W3034010729 @default.
• W4200326863 cites W3091900404 @default.
• W4200326863 cites W3147815484 @default.
• W4200326863 doi "https://doi.org/10.2174/1871520622666211228105556" @default.
• W4200326863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34963435" @default.
• W4200326863 hasPublicationYear "2022" @default.
• W4200326863 type Work @default.
• W4200326863 citedByCount "0" @default.
• W4200326863 crossrefType "journal-article" @default.
• W4200326863 hasAuthorship W4200326863A5001114156 @default.
• W4200326863 hasAuthorship W4200326863A5004970725 @default.
• W4200326863 hasAuthorship W4200326863A5008758296 @default.
• W4200326863 hasAuthorship W4200326863A5012605139 @default.
• W4200326863 hasAuthorship W4200326863A5021988496 @default.
• W4200326863 hasAuthorship W4200326863A5041191047 @default.
• W4200326863 hasAuthorship W4200326863A5044808634 @default.
• W4200326863 hasAuthorship W4200326863A5083560821 @default.
• W4200326863 hasConcept C104317684 @default.
• W4200326863 hasConcept C121608353 @default.
• W4200326863 hasConcept C159110408 @default.
• W4200326863 hasConcept C185592680 @default.
• W4200326863 hasConcept C202751555 @default.
• W4200326863 hasConcept C2775905019 @default.
• W4200326863 hasConcept C2777752497 @default.
• W4200326863 hasConcept C41685203 @default.
• W4200326863 hasConcept C526805850 @default.
• W4200326863 hasConcept C54355233 @default.
• W4200326863 hasConcept C55493867 @default.
• W4200326863 hasConcept C69366308 @default.
• W4200326863 hasConcept C71924100 @default.
• W4200326863 hasConcept C81885089 @default.
• W4200326863 hasConcept C86803240 @default.
• W4200326863 hasConcept C98274493 @default.
• W4200326863 hasConceptScore W4200326863C104317684 @default.
• W4200326863 hasConceptScore W4200326863C121608353 @default.
• W4200326863 hasConceptScore W4200326863C159110408 @default.
• W4200326863 hasConceptScore W4200326863C185592680 @default.
• W4200326863 hasConceptScore W4200326863C202751555 @default.
• W4200326863 hasConceptScore W4200326863C2775905019 @default.
• W4200326863 hasConceptScore W4200326863C2777752497 @default.
• W4200326863 hasConceptScore W4200326863C41685203 @default.
• W4200326863 hasConceptScore W4200326863C526805850 @default.
• W4200326863 hasConceptScore W4200326863C54355233 @default.
• W4200326863 hasConceptScore W4200326863C55493867 @default.
• W4200326863 hasConceptScore W4200326863C69366308 @default.
• W4200326863 hasConceptScore W4200326863C71924100 @default.
• W4200326863 hasConceptScore W4200326863C81885089 @default.
• W4200326863 hasConceptScore W4200326863C86803240 @default.
• W4200326863 hasConceptScore W4200326863C98274493 @default.
• W4200326863 hasIssue "14" @default.
• W4200326863 hasLocation W42003268631 @default.
• W4200326863 hasLocation W42003268632 @default.
• W4200326863 hasOpenAccess W4200326863 @default.
• W4200326863 hasPrimaryLocation W42003268631 @default.

• next